Observational cohort study on SARS-CoV-2 evolution in immunocompromised patients
Long COVID Virus Changes Shape Inside Severely Ill Patients, Study Finds
This observational cohort study analyzed longitudinal SARS-CoV-2 genomes from 91 immunocompromised patients with COVID-19. It found that sev…
When the virus lingers too long in very sick patients, it changes in unpredictable ways, highlighting the need for stronger treatments.
Observational serological model in Malawi shows rapid SARS-CoV-2 antibody waning and urban-rural differences
Malawi Study Rewrites Rules of COVID Immunity
This observational study used serological modelling to reconstruct SARS-CoV-2 infection histories in unvaccinated Malawian adults. It found …
In Malawi, natural immunity fades fast, with antibodies dropping to 5% after one year, so vaccines remain essential for lasting protection.
Review of stepped-wedge trial on Montessori approaches for nursing home staff during COVID-19
Nursing Home Residents Found a Lifeline in the Pandemic's Darkest Days
This publication is a review of a stepped-wedge, randomized clinical trial involving 1,117 nursing home staff from 8 Veterans Administration…
When COVID-19 cut nursing home residents off from family, a care method rooted in choice and engagement helped keep residents and staff from…
Methodological review assesses phenotypes for classifying respiratory viruses in English health data
How Doctors Track RSV, Flu, and COVID When Tests Aren't Always Done
This methodological review evaluates phenotypes for classifying respiratory viruses like RSV, influenza, and COVID-19 in English coded healt…
Coded health records can now identify RSV, flu, and COVID-19 outbreaks without lab tests, helping public health agencies track disease trend…
Review describes scalable testing workflow for emerging infectious diseases
Frequent Testing Beat Lockdowns at Stopping Viral Spread
This after-action report review synthesizes a scalable workflow for specimen collection, analysis, and reporting during the COVID-19 pandemi…
Frequent testing with same-day results stopped viral spread better than lockdowns, proving rapid monitoring protects communities when new vi…
Phase 1 cohort study assesses prophylactic pDNA vaccine safety and immunogenicity in healthy adults.
Early study of a COVID-19 DNA vaccine in healthy adults showed no serious safety issues.
This Phase 1 cohort study enrolled 42 eligible healthy subjects to evaluate a prophylactic COVID-19 pDNA vaccine compared to placebo (Saline…
A new COVID-19 DNA vaccine showed no serious safety issues in healthy adults after six months of monitoring.
Plasma hyaluronic acid levels predict ARDS and intubation in adult COVID-19 patients.
Could a simple blood test help predict who needs breathing support for COVID-19?
This retrospective single-center cohort study evaluated plasma hyaluronic acid (HA) levels in 502 adult patients with COVID-19. HA demonstra…
High levels of a specific blood substance linked to severe lung trouble could help doctors spot who needs breathing support for COVID-19 soo…
Hospitalized COVID-19 patients receiving antiviral, antiretroviral, or immunosuppressive treatments showed variable outcomes.
What helps hospitalized COVID-19 patients survive? A new model offers clues.
This cohort study of 711 hospitalized subjects with coronavirus evaluated antiviral, antiretroviral, and immunosuppressive treatments. Resul…
When COVID-19 hits hard, doctors need better tools to predict who might get worse. A study of 711 hospitalized patients found that factors l…
Mini-review links insulin to worse COVID-19 outcomes in type 2 diabetes patients
Diabetes Meds Do Not Stop COVID-19
A mini-review of observational studies in patients with type 2 diabetes mellitus found that insulin was linked to worse COVID-19 outcomes, w…
Recent research proves that common diabetes pills do not protect you from getting sick or dying from a virus infection.
Systematic review synthesizes immune and genetic factors in African SARS-CoV-2 populations
Why Africa saw milder COVID-19
This narrative synthesis reviews 40 studies from African settings regarding SARS-CoV-2 infection. The authors describe widespread pre-existi…
Africa saw milder COVID-19 because unique genes and immune defenses helped people fight the virus without getting severely sick.
COVID-19 and vitamin D status linked to IL-6 and IL-18 levels in children
Low Vitamin D Linked to Higher Inflammation in Kids
This cohort study of 170 children aged 1–17 years with PCR-confirmed SARS-CoV-2 infection measured serum IL-6 and IL-18 in relation to vitam…
Low vitamin D might make inflammation worse in children with COVID-19, but doctors need more proof before changing treatment plans.
AZD7442 showed no benefit over placebo and increased rehospitalization risk in hospitalized COVID-19 adults.
A COVID Antibody Drug That Looked Promising Didn't Deliver
This Phase 3 randomized multicentre trial evaluated tixagevimab-cilgavimab (AZD7442) versus placebo in 237 hospitalized adults with PCR-conf…
A rigorous 15-month trial found that a promising COVID antibody drug offered no clinical benefit to hospitalized patients and led to more re…